The latest price target for Rentokil Initial (NYSE:RTO) was reported by UBS on March 12, 2026. The analyst firm set a price target for $0.00 expecting RTO to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Rentokil Initial (NYSE:RTO) was provided by UBS, and Rentokil Initial upgraded their buy rating.

The last upgrade for Rentokil Initial PLC happened on March 12, 2026 when UBS raised their price target to N/A. UBS previously had a neutral for Rentokil Initial PLC.

The last downgrade for Rentokil Initial PLC happened on September 19, 2024 when Redburn Atlantic changed their price target from N/A to N/A for Rentokil Initial PLC.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Rentokil Initial, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Rentokil Initial was filed on March 12, 2026 so you should expect the next rating to be made available sometime around March 12, 2027.

While ratings are subjective and will change, the latest Rentokil Initial (RTO) rating was a upgraded with a price target of $0.00 to $0.00. The current price Rentokil Initial (RTO) is trading at is $32.11, which is out of the analyst’s predicted range.